Liontrust Investment Partners LLP lowered its position in Danaher Corporation (NYSE:DHR - Free Report) by 17.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 91,240 shares of the conglomerate's stock after selling 19,385 shares during the period. Liontrust Investment Partners LLP's holdings in Danaher were worth $18,704,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in the stock. FAS Wealth Partners Inc. grew its stake in shares of Danaher by 20.6% in the fourth quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after acquiring an additional 1,639 shares during the period. MGO One Seven LLC increased its holdings in Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock valued at $5,145,000 after acquiring an additional 20,813 shares during the last quarter. Asahi Life Asset Management CO. LTD. bought a new position in Danaher during the first quarter valued at approximately $539,000. Horizon Financial Services LLC increased its holdings in shares of Danaher by 20,400.0% in the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after buying an additional 8,160 shares during the last quarter. Finally, EFG Asset Management Americas Corp. raised its position in Danaher by 13.1% during the first quarter. EFG Asset Management Americas Corp. now owns 36,080 shares of the conglomerate's stock valued at $7,396,000 after purchasing an additional 4,191 shares during the period. 79.05% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on DHR shares. Robert W. Baird upped their price target on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. Deutsche Bank Aktiengesellschaft reduced their price objective on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Argus lowered their target price on shares of Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Jefferies Financial Group decreased their price objective on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. lowered their target price on Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $247.61.
View Our Latest Analysis on Danaher
Danaher Stock Up 1.5%
DHR traded up $3.2250 during trading hours on Tuesday, reaching $212.2350. 4,797,046 shares of the stock traded hands, compared to its average volume of 4,230,955. The company has a market cap of $151.97 billion, a price-to-earnings ratio of 45.16, a PEG ratio of 2.94 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm's fifty day simple moving average is $200.14 and its two-hundred day simple moving average is $199.45. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same quarter in the prior year, the business earned $1.72 earnings per share. Danaher's quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading

Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.